Tuesday, 27 January 2015

Swiss drug maker Novartis posts Q4 profit drop




Swiss pharmaceutical giant Novartis AG says fourth quarter net income dropped 26 percent but the company still posted a healthy 2014 annual profit.


The Basel, Switzerland-based company said Tuesday that fourth quarter net income came in at $1.49 billion, down from $2 billion in the same quarter the year before excluding its blood-transfusion diagnostics unit, which it sold in 2013. Novartis took a one-time charge of $1.1 billion in the quarter connected to the sale of its flu vaccine business.


Year-end profit rose to $10.3 billion in 2014, a 12 percent increase over 2013's $9.6 billion excluding the diagnostics unit.


CEO Joseph Jimenez said in 2014 Novartis "delivered solid sales growth with margin expansion, strengthened innovation and advanced our quality and productivity."



© 2015 The Associated Press. All rights reserved.


Medical Xpress on facebook

Related Stories


Novartis Q4 net profit rises to $2.0 billion


Jan 29, 2014



Swiss drug maker Novartis AG reported a 2 percent rise in fourth-quarter net profit Wednesday, helped by delays in generic competition to its blockbuster drugs.



Novartis cites momentum in three percent profit rise


Jul 17, 2014



Swiss pharmaceutical company Novartis AG posted a 3 percent rise in second-quarter profits Thursday, reflecting what it described as solid growth and an increased focus on core products.



New drug sales help boost Novartis Q1 profit (Update)


Apr 24, 2014



Strong new drug sales and higher operating income helped Swiss pharmaceutical firm Novartis AG report a 24 percent rise in first-quarter profit.



Swiss pharma Novartis ups full-year sales outlook (Update)


Oct 22, 2013



Swiss pharmaceutical giant Novartis AG raised its full-year sales outlook because of delays in generic competition to its blockbuster blood pressure drug Diovan, even though it said negative currency trends ...



Novartis selling flu vaccine unit to CSL for $275M


Oct 27, 2014



Australian drugmaker CSL Ltd. said Monday it will buy Novartis' flu vaccine business for $275 million.



Recommended for you


Uganda sued in landmark medical 'brain drain' case


1 hour ago



Raymond Mwesiga's "darling kid sister" had much to live for, but when she needed medical help after a car crash, Uganda's overstretched health system fatally failed her.



Is head CT overused in emergency departments?


18 hours ago



Less than 7.1% of patients presenting to the emergency department with dizziness and 6.4% complaining of syncope or near-syncope benefited from head CT say researchers at Kaiser Foundation Hospital in Honolulu. The use of ...



Majority of primary care physicians find that medical imaging improves patient care


19 hours ago



According to a study published online in the Journal of the American College of Radiology (JACR), large majorities of primary care physicians believe that advanced medical imaging, such as computed tomography (CT), magneti ...





Medical radiation may be reduced to one-sixth


20 hours ago



One of this century's most significant mathematical discoveries may reduce the number of measuring points to one-sixth of the present level. This means reduced exposure to radiation and faster medical imaging ...



The 'fifth taste,' umami, could be beneficial for health


Jan 25, 2015



The umami taste could have an important and beneficial role in health, according to research published in the open access journal Flavour. The journal's special series of articles 'The Science of Taste' also finds that ' ...





Video shows blind mother seeing baby for first time


Jan 25, 2015



A video that went viral this week showed a legally blind mother in Canada getting to look at her newborn child for the first time thanks to vision-enhancing glasses.



User comments



Please sign in to add a comment. Registration is free, and takes less than a minute. Read more


Click here to reset your password.

Sign in to get notified via email when new comments are made.







Swiss pharmaceutical giant Novartis AG says fourth quarter net income dropped 26 percent but the company still posted a healthy 2014 annual profit.


The Basel, Switzerland-based company said Tuesday that fourth quarter net income came in at $1.49 billion, down from $2 billion in the same quarter the year before excluding its blood-transfusion diagnostics unit, which it sold in 2013. Novartis took a one-time charge of $1.1 billion in the quarter connected to the sale of its flu vaccine business.


Year-end profit rose to $10.3 billion in 2014, a 12 percent increase over 2013's $9.6 billion excluding the diagnostics unit.


CEO Joseph Jimenez said in 2014 Novartis "delivered solid sales growth with margin expansion, strengthened innovation and advanced our quality and productivity."



© 2015 The Associated Press. All rights reserved.


Medical Xpress on facebook

Related Stories


Novartis Q4 net profit rises to $2.0 billion


Jan 29, 2014



Swiss drug maker Novartis AG reported a 2 percent rise in fourth-quarter net profit Wednesday, helped by delays in generic competition to its blockbuster drugs.



Novartis cites momentum in three percent profit rise


Jul 17, 2014



Swiss pharmaceutical company Novartis AG posted a 3 percent rise in second-quarter profits Thursday, reflecting what it described as solid growth and an increased focus on core products.



New drug sales help boost Novartis Q1 profit (Update)


Apr 24, 2014



Strong new drug sales and higher operating income helped Swiss pharmaceutical firm Novartis AG report a 24 percent rise in first-quarter profit.



Swiss pharma Novartis ups full-year sales outlook (Update)


Oct 22, 2013



Swiss pharmaceutical giant Novartis AG raised its full-year sales outlook because of delays in generic competition to its blockbuster blood pressure drug Diovan, even though it said negative currency trends ...



Novartis selling flu vaccine unit to CSL for $275M


Oct 27, 2014



Australian drugmaker CSL Ltd. said Monday it will buy Novartis' flu vaccine business for $275 million.



Recommended for you


Uganda sued in landmark medical 'brain drain' case


1 hour ago



Raymond Mwesiga's "darling kid sister" had much to live for, but when she needed medical help after a car crash, Uganda's overstretched health system fatally failed her.



Is head CT overused in emergency departments?


18 hours ago



Less than 7.1% of patients presenting to the emergency department with dizziness and 6.4% complaining of syncope or near-syncope benefited from head CT say researchers at Kaiser Foundation Hospital in Honolulu. The use of ...



Majority of primary care physicians find that medical imaging improves patient care


19 hours ago



According to a study published online in the Journal of the American College of Radiology (JACR), large majorities of primary care physicians believe that advanced medical imaging, such as computed tomography (CT), magneti ...





Medical radiation may be reduced to one-sixth


20 hours ago



One of this century's most significant mathematical discoveries may reduce the number of measuring points to one-sixth of the present level. This means reduced exposure to radiation and faster medical imaging ...



The 'fifth taste,' umami, could be beneficial for health


Jan 25, 2015



The umami taste could have an important and beneficial role in health, according to research published in the open access journal Flavour. The journal's special series of articles 'The Science of Taste' also finds that ' ...





Video shows blind mother seeing baby for first time


Jan 25, 2015



A video that went viral this week showed a legally blind mother in Canada getting to look at her newborn child for the first time thanks to vision-enhancing glasses.



User comments



Please sign in to add a comment. Registration is free, and takes less than a minute. Read more


Click here

to reset your password.


Sign in to get notified via email when new comments are made.









Categories:

0 comments:

Post a Comment